90 related articles for article (PubMed ID: 3408950)
1. Screening for neuroblastoma.
Draper GJ
BMJ; 1988 Jul; 297(6642):152-3. PubMed ID: 3408950
[No Abstract] [Full Text] [Related]
2. Unpurged autologous bone marrow transplantation for neuroblastoma: the AIEOP-BMT group experience.
Dini G; Lanino E; Garaventa A; Paolucci P; Amici A; Locatelli F; Colleselli P; Boni L; Dallorso S; Abla O
Bone Marrow Transplant; 1991; 7 Suppl 3():109-11. PubMed ID: 1855071
[No Abstract] [Full Text] [Related]
3. [Neuroblastoma in children: clinical and biological aspects. An experience of screening in France].
Mathieu P; Favrot M; Frappaz D; Chauvin F; Greffe J; Montegue A; Lacroix C; David L; Brunat-Mentigny M; Philip T
Ann Biol Clin (Paris); 1993; 51(7-8):665-88. PubMed ID: 8166384
[TBL] [Abstract][Full Text] [Related]
4. Mass screening for neuroblastoma in infancy. The Japanese Mass Screening Study Group of Neuroblastoma.
Sawada T; Sugimoto T; Matsumura T; Tunoda A; Takeda T; Yamamoto K; Koide R; Nagahara N; Hanawa Y; Nishihira K
Prog Clin Biol Res; 1988; 271():525-34. PubMed ID: 3406016
[No Abstract] [Full Text] [Related]
5. Neuroblastoma mass screening in infancy in Kyoto, Japan.
Sawada T; Kawakatsu H; Sugimoto T; Horii Y; Kuroda K; Hosoi H; Saida T; Hino T; Michihata T
Indian J Pediatr; 1987; 54(6):874-82. PubMed ID: 3440599
[No Abstract] [Full Text] [Related]
6. Mass screening for neuroblastoma in Japan. Committee of the Neuroblastoma Mass Screening Study of the Japanese Society of Pediatric Oncology.
Sawada T; Nagahara N; Yamamoto K; Okabe I; Hanawa Y; Hashizume K; Matsui I; Okawa H; Tsunoda A; Sakurai M
Acta Paediatr Jpn; 1990 Dec; 32(6):725-33. PubMed ID: 2082676
[TBL] [Abstract][Full Text] [Related]
7. Screening for neuroblastoma.
Lancet; 1987 Nov; 2(8569):1204. PubMed ID: 2890821
[No Abstract] [Full Text] [Related]
8. Screening for neuroblastoma.
Weinblatt M
Pediatrics; 1988 Jan; 81(1):175-7. PubMed ID: 3336591
[No Abstract] [Full Text] [Related]
9. Effects of mass screening on age-specific incidence of neuroblastoma.
Bessho F
Int J Cancer; 1996 Aug; 67(4):520-2. PubMed ID: 8759611
[TBL] [Abstract][Full Text] [Related]
10. Screening for neuroblastoma.
Pastore G; Merletti F; Magnani C
Lancet; 1984 Sep; 2(8405):752. PubMed ID: 6148501
[No Abstract] [Full Text] [Related]
11. Analysis of 598 cases of neuroblastoma (NB) detected by screening and changes in the age distribution and incidence of NB patients after mass screening in infants in Japan. NB Screening Study Group.
Sawada T; Shikata T; Matsumura T; Kawakatsu H; Sugimoto T
Prog Clin Biol Res; 1994; 385():371-5. PubMed ID: 7972233
[No Abstract] [Full Text] [Related]
12. Neuroblastoma trends in Osaka, Japan, and Great Britain 1970-1994, in relation to screening.
Honjo S; Doran HE; Stiller CA; Ajiki W; Tsukuma H; Oshima A; Coleman MP
Int J Cancer; 2003 Feb; 103(4):538-43. PubMed ID: 12478672
[TBL] [Abstract][Full Text] [Related]
13. Effects of the Cessation of Mass Screening for Neuroblastoma at 6 Months of Age: A Population-Based Study in Osaka, Japan.
Ioka A; Inoue M; Yoneda A; Nakamura T; Hara J; Hashii Y; Sakata N; Yamato K; Tsukuma H; Kawa K
J Epidemiol; 2016; 26(4):179-84. PubMed ID: 26548355
[TBL] [Abstract][Full Text] [Related]
14. Incidental neuroblastoma.
Sawada T; Kawakatu H; Horii Y; Sugimoto T
Lancet; 1988 Feb; 1(8581):364. PubMed ID: 2893178
[No Abstract] [Full Text] [Related]
15. The incidence and mortality rates of neuroblastoma cases before and after the cessation of the mass screening program in Japan: A descriptive study.
Shinagawa T; Kitamura T; Katanoda K; Matsuda T; Ito Y; Sobue T
Int J Cancer; 2017 Feb; 140(3):618-625. PubMed ID: 27778323
[TBL] [Abstract][Full Text] [Related]
16. Mass screening and age-specific incidence of neuroblastoma in Saitama Prefecture, Japan.
Yamamoto K; Hayashi Y; Hanada R; Kikuchi A; Ichikawa M; Tanimura M; Yoshioka S
J Clin Oncol; 1995 Aug; 13(8):2033-8. PubMed ID: 7636545
[TBL] [Abstract][Full Text] [Related]
17. Trend in the number of registrations for neuroblastoma in Japan.
Kawada T
Jpn J Clin Oncol; 2012 Apr; 42(4):357-8. PubMed ID: 22345704
[No Abstract] [Full Text] [Related]
18. Poor prognosis neuroblastoma: is screening the answer?
Craft AW; Parker L
Br J Cancer Suppl; 1992 Aug; 18():S96-101. PubMed ID: 1503935
[TBL] [Abstract][Full Text] [Related]
19. Effects of mass screening for neuroblastoma and the presumptive natural history of this tumor.
Takeda T; Shimada M; Iizuka S; Takasugi N
Prog Clin Biol Res; 1994; 385():383-8. PubMed ID: 7972235
[TBL] [Abstract][Full Text] [Related]
20. [Neuroblastoma and mass examination].
Sawada T; Tanaka T
Kango Gijutsu; 1985 Jun; 31(8):1109-11. PubMed ID: 3848548
[No Abstract] [Full Text] [Related]
[Next] [New Search]
